University of Minnesota. Driven to Discover.
The WHO is stepping up its response in Europe, as cases surge in Tunisa and researchers plot at-risk US sites.
Some illnesses reflect restaurant clusters linked to contaminated basil, cilantro.
In another new development, the NIH today announced the start of the first human trial of a live attenuated vaccine against Zika.
In addition, Mexico reports two highly pathogenic H7N3 outbreaks in poultry.
The findings add more weight to calls for more broadly protective flu vaccines.
Also, the species might be resistant to cold temperatures.
Of 76 patients with available information, 35 (46%) required hospitalization.
A separate study found Zika virus in the saliva of 5 different mosquito species in Mexico.
Also, reseachers identify a Zika antibody that might open up new therapy and vaccine possibilities.
The cost study looked at different attack-rate ranges, putting the upper-end estimate at as much as $2 billion.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.